Phosphatidylserine expression on the platelet membrane of patients with myeloproliferative disorders and its effect on platelet-dependent thrombin formation

Clinical and Applied Thrombosis/Hemostasis

Volumn 8, Issue 1, 2002, Pages 33-39

  Presseizen, Katya ^a   Friedman, Ziva ^a   Shapiro, Hava ^a   Radnay, Judith ^a,b   Ellis, Martin H ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Myeloproliferative; Phosphatidylserine; Prothrombinase

Indexed keywords

BLOOD CLOTTING FACTOR 10A; LIPOCORTIN 5; PHOSPHATIDYLSERINE;

ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; ENZYME ASSAY; HUMAN; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE MEMBRANE; THROMBOEMBOLISM; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 0036110307     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960200800104     Document Type: Article

References (25)

1. Primary thrombocythemia
2. Polycythemia vera: The natural history of 1213 patients followed for 20 years
3. Hydroxyurea for patients with essential thrombocythemia and a high risk for thrombosis
4. Issues in the diagnosis and management of essential thrombocythemia
5. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells
6. Generation of phenotypically aged phosphatidylserine-expressing erythrocytes by dilauoylphosphatidylcholin-induced vesiculation
7. Phospholipid asymmetry in health and disease
8. Congenital disorders of platelet function
9. Platelet activation
10. Platelet procoagulant activity: Physiological significance and mechanisms of exposure
11. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets
12. Platelet prothrombinase activity and intracellular calcium responses in patients with storage pool deficiency, glycoprotein IIb-IIIa deficiency or impaired platelet coagulant activity: A comparison with Scott syndrome
13. Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets
14. 2+ responses
15. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis
16. In vivo platelet activation correlates with red cell anionic phospholipid exposure in patients with thalassemia major
17. Phosphatidylserine in the outer leaflet of red blood cells from thalassemia major patients may explain the chronic hypercoagulable state and thrombotic episodes
18. Platelet prothrombin converting activity in hereditary disorders of platelet function
19. Scott syndrome, characterized by impaired transmembrane migration of procoagulant phosphatidylserine and hemorrhagic complications, is an inherited disorder
20. 2+-induced tyrosine phosphorylation and defective lipid scrambling in erythrocytes from a patient with Scott syndrome: A study using an inhibitor for scramblase that mimics the defect in Scott syndrome
21. Aminophospholipid exposure, microvesiculation and abnormal protein tyrosine phosphorylation in the platelets of a patient with Scott syndrome: A study using physiologic agonists and local anaesthetics
22. Experience of the polycythemia vera study group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment
23. 2-glycoprotein 1 inhibit phospholipid dependent coagulation reactions
24. Bleeding and thrombosis in myeloproliferative disorders: Mechanisms and treatment
25. Phospholipid determination in platelets, plasma and red cells of patients with chronic myeloproliferative syndromes